- testing |
No Record Found
Sector
PharmaceuticalsOpen
₹680Prev. Close
₹650Turnover(Lac.)
₹23.19Day's High
₹680Day's Low
₹64252 Week's High
₹1,163.552 Week's Low
₹611.05Book Value
₹0Face Value
₹10Mkt Cap (₹ Cr.)
759.3P/E
38.78EPS
16.76Divi. Yield
0.232 Sep 2025
12:00 AM
AGM
Announcement Date: 02 Sep, 2025
30 Jun 2025
12:00 AM
Bonus
1 Nov 2025
12:00 AM
Board Meeting
Agenda : Audited Result
10 Nov 2025
12:00 AM
Dividend
Dividend Amount: 0.5
Record Date: 14 Nov, 2025
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 5.89 | 1.47 | 1.09 | 1 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 236.33 | 152.08 | 18.05 | 5.58 |
Net Worth | 242.22 | 153.55 | 19.14 | 6.58 |
Minority Interest |
No Record Found
No Record Found
No Record Found
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 |
|---|---|---|
Gross Sales | 620.36 | 212.94 |
Excise Duty | 0 | 0 |
Net Sales | 620.36 | 212.94 |
Other Operating Income | 0 | 0 |
Other Income | 4.98 | 2.83 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,627.9 | 89.55 | 3,90,827.67 | 705.44 | 0.98 | 5,651.21 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 5,952.5 | 62.94 | 1,58,227.24 | 696 | 0.5 | 2,660 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,987.2 | 63.28 | 1,35,044.81 | 597 | 0.15 | 2,707 | 249.82 |
Cipla Ltd CIPLA | 1,311.6 | 23.13 | 1,05,960.63 | 616.88 | 1.22 | 4,256.93 | 411.55 |
Dr Reddys Laboratories Ltd DRREDDY | 1,182.5 | 21.27 | 98,682.52 | 90.6 | 0.68 | 4,266.4 | 377.56 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman(Non Exe)&Dir(Non-Ind)
SWAPNIL JATINBHAI SHAH
Managing Director
ARPIT DEEPAKKUMAR SHAH
Whole-time Director
Roma Vinodbhai Shah
Non-Exec & Non-Independent Dir
Anar Swapnil Shah
Independent Non Exe. Director
Vishrut Chandramauli Pathak
Independent Non Exe. Director
Balwant Purohit
Independent Non Exe. Director
Sanjana Sanjeev Shah
Company Sec. & Compli. Officer
Deval Patel
1101 to 1103 South Tower One42,
B/H Ashok Vatika Amblibopal Rd,
Gujarat - 380054
Tel: 91-079-29999857
Website: https://www.remuspharma.com
Email: cs@remuspharma.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: https://in.mpms.mufg.com
Email: rnt.helpdesk@in.mpms.mufg.com
Summary
Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by t...
Read More
Reports by Remus Pharmaceuticals Ltd
What is the Remus Pharmaceuticals Ltd share price today?
What is the Market Cap of Remus Pharmaceuticals Ltd?
What is the PE and PB ratio of Remus Pharmaceuticals Ltd?
What is the 52 Week High and Low of Remus Pharmaceuticals Ltd?
What is the CAGR of Remus Pharmaceuticals Ltd?
What is the shareholding pattern of Remus Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.